ReviewNeurology and therapy2026

Disease-Modifying Therapies for Hereditary Transthyretin Amyloidosis with Polyneuropathy: Current Status and Future Perspectives.

Toshihiro Ide et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.